MD Medical Group`s Vitaly Ustimenko Attended Russian CFO Summit
Vitaly Ustimenko, Chief Financial Officer at MD Medical Group Investments Plc ("MD Medical Group", "MDMG" or the "Company" - LSE: MDMG), Russia's leading provider of private women's and children's healthcare, presented at the 10th Annual Adam Smith Russian CFO Summit in Moscow.
More than 100 CFOs from leading domestic and multinational corporates in Russia gathered to discuss key issues facing the finance profession, ranging from the strategic role of the CFO; the CFO as a change leader; capital markets and raising finance; M&A; and effective stakeholder engagement.
Alongside speakers from MTS, Formula Kino and Raspadskaya, Vitaly delivered a presentation in the session dedicated to effective stakeholder management, giving insight into the company's highly successful London IPO in October 2012, and the challenges of managing new stakeholder relationships as a newly listed company.
This was Vitaly's second appearance this year in the Adam Smith Russian CFO series, having participated in the CFO Awards in May where he was given the award for Best Russian IPO of the Year.
This press release contains forward looking statements, which are based on the Company’s current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company’s ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.
No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.
2020 2019 2018 2017 2016 2015 2014 2013 2012